Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Cardiovascular Conditions
    • Commentary
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Hematology
    • Hereditary Genetic Disorders
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Nephrologic/Hepatologic Conditions
    • Neurological Diseases
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jheor.org/feed
×
Cardiovascular Conditions
Vol. 4, Issue 1, 2016 January 28, 2016 EDT

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

Xavier Granero Xiberta , Antonio Murcia , José Ricardo Troncoso Durán , Claudio Gómez Zubeldia , Aleix Llorac Moix , Ruth Graefenhain De Codes , Maria Giovana Ferrario , Luis Lizán ,
  • budget impact
  • enoxaparin
  • rivaroxaban
  • major orthopedic surgery
  • total knee replacement
  • total hip replacement
  • antithrombotic prophylaxis
ccby-4.0 • https://doi.org/10.36469/9824
Photo by Piron Guillaume on Unsplash
JHEOR
1.
Granero Xiberta X, Murcia A, Troncoso Durán JR, et al. Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain. JHEOR. 2016;4(1):35-46. doi:10.36469/9824
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)
Powered by Scholastica, the modern academic journal management system